Evaluation of Efficacy and Safety of Symbicort® as an add-on Treatment to Spiriva® in Patients With Severe COPD.
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effect of combined treatment with Symbicort
and Spiriva, in terms of improvement of lung function, symptoms and inflammatory markers, in
patients with severe COPD.